Import Biofin Anti Cellulite Cream — Buy in wholesale FOB from Supplier in Turkey

Biofin Anti Cellulite Cream from Biofin Cosmetics is a topical cosmetic formulation designed to address cellulite across stages from early to more established deposits. The product is positioned as a skin-firming treatment with immediate perceptual benefits, specifically the sensation of toned and lighter skin following initial application. Its natural-scent profile indicates fragrance integration rather than unfragranced medical-grade positioning, which shapes its regulatory classification and market channel suitability.

The formulation relies on a natural-ingredient claim, though the specific active complexes, whether caffeine, retinol, centella asiatica, or botanical extracts, are not disclosed in the source data. Typical anti-cellulite creams incorporate lipolytic agents, microcirculation stimulants, and connective-tissue support compounds at concentrations between 2% and 10% for key actives. Base vehicle composition, whether aqueous gel, emulsion, or oil-in-water cream, determines absorption rate, occlusivity, and application frequency, standard daily use being typical for this category.

Primary buyers include aesthetic clinics, spa chains, dermatology-adjacent retail, and e-commerce operators targeting the body-contouring segment. The product's positioning as suitable for both early and stubborn cellulite suggests broad consumer demographic applicability rather than clinical-grade prescription. Importers should verify whether Biofin Cosmetics formulates under GMP cosmetic standards, holds ISO 22716 certification, or has completed EU CPR notification, as these determine market-access pathways across European, Middle Eastern, and Asian jurisdictions.

Biofin Cosmetics maintains its registered address in Istanbul, 34000, Turkey, placing its operations within Turkey's largest commercial and logistics hub with established cosmetic manufacturing infrastructure. The supplier holds a harbor trust tier, which represents a baseline verification level rather than an advanced or premium tier. The response rate is recorded at 0.00 with an average response time of zero hours, indicating either a new listing profile, inactive inquiry management, or a data-capture anomaly that prospective buyers should clarify directly before relying on responsiveness assumptions.

The supplier's disclosed product range centers on the Biofin branded line, spanning body care and baby care segments, suggesting a family-brand strategy rather than white-label or contract-manufacturing orientation. No information is provided on production facility scale, annual output, R&D capability, third-party audit status, or export experience. Buyers should request documentation on manufacturing standards, quality-control protocols, and existing distributor or retail partnerships to assess operational maturity and supply-chain reliability.